Dimensional Fund Advisors’s Roivant Sciences ROIV Stock Holding History

Dimensional Fund Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$185M	Sell	5,230,417 -2,245,449	-30%	-$66.4M	0.03%	720
2026 Q1	$207M	Sell	7,475,866 -1,771,602	-19%	-$45.5M	0.04%	557
2025 Q4	$201M	Sell	9,247,468 -61,242	-0.7%	-$1.21M	0.04%	557
2025 Q3	$141M	Buy	9,308,710 +1,423,074	+18%	+$17.6M	0.03%	808
2025 Q2	$88.9M	Buy	7,885,636 +5,297,818	+205%	+$57.4M	0.02%	1111
2025 Q1	$26.1M	Buy	2,587,818 +2,456,504	+1,871%	+$26.6M	0.01%	1816
2024 Q4	$1.55M	Sell	131,314 -71,627	-35%	-$847K	﹤0.01%	2842
2024 Q3	$2.34M	Sell	202,941 -49,780	-20%	-$567K	﹤0.01%	2751
2024 Q2	$2.67M	Buy	+252,721	New	+$2.77M	﹤0.01%	2685

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Dimensional Fund Advisors's ROIV Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Roivant Sciences (ROIV) stake by 30% in Q2 2026, selling an estimated $66.4M and leaving 5,230,417 shares worth $185M. The position accounts for 0.03% of the portfolio, ranked #720.

Dimensional Fund Advisors first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. The position peaked at $207M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Dimensional Fund Advisors held 5,230,417 shares of Roivant Sciences worth $185M as of Q2 2026.
Dimensional Fund Advisors sold 2,245,449 Roivant Sciences shares in Q2 2026, an estimated $66.4M.
Roivant Sciences made up 0.03% of Dimensional Fund Advisors's portfolio in Q2 2026, its #720 holding.
Dimensional Fund Advisors first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
Dimensional Fund Advisors's Roivant Sciences position peaked at $207M in Q1 2026.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.